share_log

22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024

22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024

22nd Century Group(XXII)將於2024年5月15日公佈2024年第一季度業績
newsfile ·  05/07 08:15

Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live webcast on Wednesday, May 15, 2024, at 8:00 AM ET to discuss its 2024 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.

北卡羅來納州莫克斯維爾--(Newsfile Corp.,2024年5月7日)——專注於減少菸草危害以改善健康和保健的菸草公司22世紀集團公司(納斯達克股票代碼:XXII)將於美國東部時間2024年5月15日星期三上午8點舉辦網絡直播,討論其2024年第一季度業績,該業績將在美國東部時間當天上午6點的新聞稿中公佈。

During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.

在網絡直播中,董事長兼首席執行官拉里·費爾斯通和首席財務官丹·奧托將審查財務業績並討論最近幾個月取得的進展。

Following management's prepared remarks and slide presentation, the Company will host a Q&A session, during which management will accept questions from research analysts.

在管理層準備好的講話和幻燈片演示之後,公司將舉辦問答環節,在此期間,管理層將接受研究分析師的提問。

The live and archived webcast and slide presentation will be accessible on the Events web page in the Company's Investor Relations section of the website, at . Please access the website at least 15 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.

直播和存檔的網絡直播和幻燈片演示可在公司投資者關係部分的活動網頁上訪問,網址爲。請在網絡直播開始前至少 15 分鐘訪問該網站進行註冊,並在必要時下載並安裝任何必需的軟件。

About 22nd Century Group, Inc.

關於 22 世紀集團有限公司

22nd Century Group, Inc. (NASDAQ: XXII) is a tobacco company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA's Comprehensive Plan to address the widespread death and disease caused by smoking. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.

22nd Century Group, Inc.(納斯達克股票代碼:XXII)是一家菸草公司,專注於減少菸草危害、減少尼古丁菸草和改善健康狀況。該公司擁有數十項專利,允許其控制菸草廠中的尼古丁生物合成,開發了專有的降低尼古丁含量(RNC)菸草植物和香菸,這些植物和香菸已成爲美國食品藥品管理局解決吸菸引起的大量死亡和疾病的綜合計劃的基石。2021年12月,該公司獲得了美國食品藥品管理局第一份也是唯一一款可燃香菸草產品(MRTP)授權。22nd Century使用現代植物育種技術,包括基因工程、基因編輯和分子育種,通過創造具有優化生物鹼和類黃酮特徵以及提高產量和有價值農藝特徵的新專有植物,爲生命科學和消費品行業提供解決方案。

Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.

在 xxiicentury.com、Twitter、LinkedIn 和 YouTube 上了解更多信息。

Learn more about VLN at tryvln.com.

了解有關 VLN 的更多信息 在 tryvln.com。

Cautionary Note Regarding Forward-Looking Statements

關於前瞻性陳述的警示說明

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024. All information provided in this press release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

除歷史信息外,本新聞稿中包含的所有陳述、預期和假設均爲前瞻性陳述,包括但不限於我們的全年業務展望。前瞻性陳述通常包含 “預測”、“相信”、“考慮”、“繼續”、“可能”、“估計”、“預期”、“探索”、“預見”、“目標”、“指導”、“打算”、“可能”、“計劃”、“潛在”、“預測”、“初步”、“可能”、“項目”、“有希望”、“尋求” 等術語、” “應該”、“將”、“將” 和類似的表達。實際結果可能與前瞻性陳述中的明示或隱含結果存在重大差異。公司於2024年3月28日提交的10-K表年度報告中的 “風險因素” 中列出了可能導致實際業績出現重大差異的重要因素。本新聞稿中提供的所有信息均爲截至本新聞稿發佈之日,除非法律要求,否則公司不承擔任何義務也不打算更新這些前瞻性陳述。

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200

投資者關係與媒體聯繫人
馬特·克雷普斯
投資者關係
22 世紀集團
mkreps@xxiicentury.com
214-597-8200

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論